Gore set to take lead in thoracic graft industry
This article was originally published in Clinica
Executive Summary
The FDA has scheduled a January 13 advisory committee meeting to review WL Gore's TAG endoprosthesis, the first product in the race to develop a competitive stent graft for the treatment of thoracic aortic aneurysms.